ICCC - ImmuCell Corp Stock Price, Fair Value and News

$5.30+0.30 (+6.00%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ICCC Price Action

Last 7 days

10.4%

Last 30 days

-14.6%

Last 90 days

-18.7%

Trailing 12 Months

15.7%

ICCC RSI Chart

ICCC Valuation

Market Cap

47.9M

Price/Earnings (Trailing)

20.63

Price/Sales (Trailing)

1.7

EV/EBITDA

9.49

Price/Free Cashflow

67.02

ICCC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ICCC Fundamentals

ICCC Revenue

Revenue (TTM)

28.3M

Rev. Growth (Yr)

17.76%

Rev. Growth (Qtr)

-20.11%

ICCC Earnings

Earnings (TTM)

2.3M

Earnings Growth (Yr)

80.08%

Earnings Growth (Qtr)

-127.84%

ICCC Profitability

EBT Margin

8.27%

Return on Equity

7.8%

Return on Assets

5.08%

Free Cashflow Yield

1.49%

ICCC Investor Care

Shares Dilution (1Y)

1.51%

Diluted EPS (TTM)

0.28

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	27.3M	28.3M	27.8M	0
2024	18.7M	20.7M	21.3M	26.5M
2023	16.0M	15.7M	16.3M	14.9M
2022	21.1M	20.5M	20.1M	18.6M
2021	14.5M	16.1M	17.5M	19.2M
2020	14.2M	14.5M	15.2M	15.3M
2019	12.5M	12.2M	13.0M	13.7M
2018	9.8M	11.0M	11.2M	11.0M
2017	10.1M	9.5M	9.5M	10.4M
2016	10.1M	10.5M	10.0M	9.5M
2015	8.6M	9.0M	9.7M	10.2M
2014	6.2M	6.4M	7.0M	7.6M
2013	5.5M	5.7M	5.9M	6.0M
2012	5.3M	5.2M	5.3M	5.4M
2011	4.6M	4.8M	4.9M	5.1M
2010	0	0	0	4.4M

Get all data in R, Python etc through our Historical Stock Data APIs

About ImmuCell Corp

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

CEO	Mr. Michael F. Brigham
WEBSITE	https://immucell.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	66

ImmuCell Corp Frequently Asked Questions

What is the ticker symbol for ImmuCell Corp? What does ICCC stand for in stocks?

ICCC is the stock ticker symbol of ImmuCell Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ImmuCell Corp (ICCC)?

As of Wed Dec 03 2025, market cap of ImmuCell Corp is 47.94 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ICCC stock?

You can check ICCC's fair value in chart for subscribers.

Is ImmuCell Corp a good stock to buy?

The fair value guage provides a quick view whether ICCC is over valued or under valued. Whether ImmuCell Corp is cheap or expensive depends on the assumptions which impact ImmuCell Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ICCC.

What is ImmuCell Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, ICCC's PE ratio (Price to Earnings) is 20.63 and Price to Sales (PS) ratio is 1.7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ICCC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on ImmuCell Corp's stock?

In the past 10 years, ImmuCell Corp has provided -0.033 (multiply by 100 for percentage) rate of return.